Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors

Molecular Pharmacology

Volumn 66, Issue 6, 2004, Pages 1599-1606

  Kadowaki, Tomoko ^a   Baba, Atsuyo ^a   Abe, Naoko ^a   Takii, Ryosuke ^a   Hashimoto, Munetaka ^a   Tsukuba, Takayuki ^a   Okazaki, Shinji ^b   Suda, Yoshimitsu ^b   Asao, Tetsuji ^b   Yamamoto, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; COLLAGEN TYPE 1; FIBRINOGEN; FIBRONECTIN; GINGIPAIN INHIBITOR; GINGIPAIN R; IMMUNOGLOBULIN; KYT 1; KYT 2; KYT 22; KYT 26; KYT 30; KYT 36; KYT 8; LYS GINGIPAIN; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; DRUG SYNTHESIS; FIBROBLAST CULTURE; GINGIVA; GROWTH INHIBITION; GUINEA PIG; HEMAGGLUTINATION; HUMAN; HUMAN CELL; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADHESINS, BACTERIAL; CELL ADHESION; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; FIBROBLASTS; GINGIVA; HEMAGGLUTINATION TESTS; HEMAGGLUTININS; HUMANS; KINETICS; PORPHYROMONAS GINGIVALIS;

EID: 9444263143     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.004366     Document Type: Article

References (40)

1. Abe N, Kadowaki T, Okamoto K, Nakayama K, Ohishi M, and Yamamoto K (1998) Biochemical and functional properties of lysine-specific cysteine proteinase (Lysgingipain) as a virulence factor of Porphyromonas gingivalis in periodontal disease. J Biochem 123:305-312.
2. Allen RC, Stjernholm RL, and Steele RH (1972) Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 47:679-684.
3. Baba A, Abe N, Kadowaki T, Nakanishi H, Ohishi M, Asao T, and Yamamoto K (2001) Arg-gingipain is responsible for the degradation of cell adhesion molecules of human gingival fibroblasts and their death induced by Porphyromonas gingivalis. Biol Chem 382:817-824.
4. Baba A, Kadowaki T, Asao T, and Yamamoto K (2002) Roles of Arg- and Lysgingipains in the disruption of cytokine responses and loss of viability of human endothelial cells by Porphyromonas gingivalis infection. Biol Chem 383:1223-1230.
5. Bando Y, Kominami E, and Katunuma N (1986) Purification and tissue distribution of rat cathepsin L. J Biochem 100:35-42.
6. Barrett AJ and Kirschke H (1981) Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol 80:535-561.
7. Beck JD, Pankow J, Tayroler HA, and Offenbacher S (1999) Dental infections and atherosclerosis. Am Heart J 138:528-533.
8. Cisar JO, Kolenbrander PE, and McIntyre FC (1979) Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Infect Immun 24:742-752.
9. Curtis MA, Aduse Opoku J, Rangarajan M, Gallagher A, Sterne JAC, Reid CR, Evans HEA, and Samuelssson B (2002) Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor. Infect Immun 70:6968-6975.
10. DeStefano F, Anda RF, Kahn HS, Williamson DF, and Russell CM (1993) Dental disease and risk of coronary heart disease and mortality. Br Med J 306:688-691.
11. Gusman H, Travis J, Helmerhorst EJ, Potempa J, Troxler RF, and Oppenheim FG (2001) Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease. Infect Immun 69:1402-1408.
12. Holt SC, Felton J, Brunsvold M, and Kornman KS (1988) Implantation of Bacteroides gingivalis in non-human primate initiates progression of periodontitis. Science (Wash DC) 239:55-67.
13. Imamura T, Pike RN, Potempa J, and Travis J (1994) Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/ kinin pathway. J Clin Investig 94:361-367.
14. Jeffcoat MK, Hauth JC, Geurs NC, Reddy MS, Cliver SP, Hodgkins PM, and Goldenberg RL (2003) Periodontal disease and preterm birth: results of a pilot intervention study. J Periodontol 74:1214-1218.
15. Kadowaki T, Nakayama K, Okamoto K, Abe N, Baba A, Shi Y, Ratnayake DB, and Yamamoto K (2000) Porphyromonas gingivalis proteinases as virulence determinants in progression of periodontal disease. J Biochem. 128:153-159.
16. Kadowaki T, Nakayama K, Yoshimura F, Okamoto K, Abe N, and Yamamoto K (1998) Arg-gingipain acts a major processing enzyme for various cell surface proteins of Porphyromonas gingivalis. J Biol Chem 273:29072-29076.
17. Kadowaki T, Yoneda M, Okamoto K, Maeda K, and Yamamoto K (1994) Purification and characterization of a novel arginine-specific cysteine proteinase (argingipain) involved in the pathogenesis of periodontal disease from the culture supernatant of Porphyromonas gingivalis. J Biol Chem 269:21371-21378.
18. Kamaguchi A, Nakayama K, Ohyama T, Watanabe T, Okamoto M, and Baba H (2001) Coaggregation of Porphyromonas gingivalis and Prevotella intermedia. Microbiol Immunol 45:649-656.
19. Mackay BJ, Denepitiya L, Iacono VJ, Krost SB, and Pollock JJ (1984) Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans. Infect Immun 44:695-701.
20. Milner P, Batten JE, and Curtis MA (1996) Development of a simple chemically defined medium for Porphyromonas gingivalis: requirement for a-ketoglutarate. FEMS Microbiol Lett 140:125-130.
21. Nakayama K, Kadowaki T, Okamoto K, and Yamamoto K (1995) Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)- deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence. J Biol Chem 270:23619-23626.
22. Nakayama K, Ratnayake DB, Tsukuba T, Kadowaki T, Yamamoto K, and Fujimura S (1998) Haemoglobin receptor protein is intragenically encoded by the cysteine proteinase-encoding genes and the haemagglutinin-encoding gene of Porphyromonas gingivalis. Mol Microbiol 27:51-61.
23. Nakayama K, Yoshimura F, Kadowaki T, and Yamamoto K (1996) Involvement of arginine-specific cysteine proteinase (Arg-gingipain) in fimbriation of Porphyromonas gingivalis. J Bacteriol 178:2818-2824.
24. Nishikata M, Kanehira T, Oh H, Tani H, Tazaki M, and Kuboki Y (1991) Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis. Biochem Biophys Res Commun. 174:625-630.
25. Okamoto K, Nakayama K, Kadowaki T, Abe N, Ratnayake DB, and Yamamoto K (1998) Involvement of a lysine-specific cysteine proteinase in hemoglobin adsorption and heme accumulation by Porphyromonas gingivalis. J Biol Chem 273: 21225-21231.
26. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, and Troxler RF (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure and fungistatic effects on Candida albicans. J Biol Chem 263:7472-7477.
27. Potempa J, Pike P, and Travis J (1995) The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun 63:1176-1182.
28. Potempa J, Pike R, and Travis J (1997) Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem 378:223-230.
29. Romero BC, Chiquito CS, Elejalde LE, and Bernardoni CB (2002) Relationship between periodontal disease in pregnant women and the nutritional condition of their newborns. J Periodontol 73:1177-1183.
30. Scannapieco FA (1999) Role of oral bacteria in respiratory infection. J Periodontol 70:793-802.
31. Shah HN and Gharbia SE (1989) Lysis of erythrocytes by the secreted cysteine proteinase of Porphyromonas gingivalis W83. FEMS Microbiol Lett 61:213-217.
32. Shapira L, Ayalon S, and Brenner T (2002) Effects of Porphyromonas gingivalis on the central nervous system: activation of glial cells and exacerbation of experimental autoimmune encephalomyelitis. J Periodontol 73:511-516.
33. Shi Y, Ratnayake DB, Okamoto K, Abe N, Yamamoto K, and Nakayama K (1999) Genetic analyses of proteolysis, hemoglobin binding, and hemaggulutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp and hagA. J Biol Chem 274:17955-17960.
34. Slots J, Bragd L, Wikström M, and Dahlen G (1986) The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol 13:570-577.
35. Teng YT, Taylor GW, Scannapieco F, Kinane DF, Curtis M, Beck JD, and Kogon S (2002) Periodontal health and systemic disorders. J Can Dent Assoc 68:188-192.
36. Towatari T, Tanaka K, Yoshikawa D, and Katunuma K (1976) Separation of a new protease from cathepsin B1 of rat liver lysosomes. FEBS Lett 67:284-288.
37. Towatari T, Tanaka K, Yoshikawa D, and Katunuma K (1978) Purification and properties of a new cathepsin from rat liver. J Biochem 84:659-678.
38. Xu T, Levitz SM, Diamond RD, and Oppenheim FG (1991) Anticandidal activity of major human salivary histatins. Infect Immun 59:2549-2554.
39. Yamaguchi T, Kasamo K, Chuman M, Machigashira M, Inoue M, and Sueda T (1998) Preparation and characterization of an Actinomyces naeslundii aggregation factor that mediates coaggregation with Porphyromonas gingivalis. J Periodontal Res 33:60-468.
40. Yoneda M, Maeda K, and Aono M (1990) Suppression of bactericidal activity of human polymorphonuclear leukocytes by Bacteroides gingivalis. Infect Immun 58:406-411.